Focus On Faculty With Nick Messinger, PharmD
Nick Messinger, PharmD, has joined the James L. Winkle College of Pharmacy as an assistant professor in a newly created non-tenure track faculty position with a focus on ambulatory care. Messingers practice site will be the Cincinnati Health Department, where associate professor Bethanne Brown, PharmD, already maintains a practice. Brown will serve as Messingers practice mentor.
Messinger earned his bachelor of science degree in biochemistry/biology (magna cum laude) from the College of Mount St. Joseph (now Mount St. Joseph University) in 2008 and his PharmD (Honors, with distinction) from the James L. Winkle College of Pharmacy in 2012. He completed a PGY1 residency at University of Cincinnati Medical Center (UCMC) in 2013 and completed his PGY2 residency in ambulatory care with the Five Rivers Health Centers in Dayton in 2014. Messinger, a Board Certified Pharmacotherapy Specialist (BCPS), worked as a staff pharmacist at UCMC and CVS Caremark.
"I am very honored and excited to be joining the faculty at the Winkle College of Pharmacy, he says. " This position will allow me to pursue both of my passions, teaching and patient care. I have learned in residency that pharmacists can make an incredible impact in a patients life and I love to share these experiences with students. I am looking forward to serving the city I have lived in my entire life
Go Bearcats!
With the addition of Messinger the college will be able to further address the health care needs of the urban, underserved population in local neighborhoods, remarked Dean Neil MacKinnon, PhD.
"I believe Nick will play an important role in this and his addition to the health department will enable more of our students to have this type of patient care experience in their advanced pharmacy practice experience rotations. There are many opportunities for scholarly work with the Cincinnati Health Department, including documenting the impact of pharmacist services on economic, clinical and humanistic outcomes, says MacKinnon.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.